microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft arnold  porter in ny gains sheppard mullin ip partner  law search advanced search take a free trial  sign in close law indepth law uk adv search  platform tools browse all sections banking bankruptcy class action competition employment energy expert analysis insurance intellectual property product liability securities rankings laws mvps glass ceiling report global  law  diversity snapshot practice group partner rankings practice groups of the year pro bono firms of the year rising stars trial aces site menu join the law team search legal jobs learn more about law read testimonials contact law sign up for our newsletters site map help make sure you dont miss any law breaking news download our plugin for chrome to get customizable realtime news alerts arnold  porter in ny gains sheppard mullin ip partner by aaron vehling law new york october    pm edt  arnold  porter llp has announced that it has snagged a sheppard mullin richter  hampton llp attorney with life sciences experience as partner to expand its corporate and intellectual property practice groups in its new york officeblaine templeman joined arnold  porter on tuesday bringing with him  years of experience helping clients navigate the complex world of domestic and international ip transactions in the life sciences realm arnold  porter chairman thomas h milch in a tuesday statement lauded templeman’s tool chest of to view the full article register now try law free for seven days already a subscriber click here to login add to briefcase printable version rightsreprints editorial contacts related sections intellectual property life sciences new york law firms arnold  porter kaye scholer sheppard mullin companies aduro biotech inc check out laws new podcast pro say which offers a weekly recap of both the biggest stories and hidden gems from the world of law listen to our latest most popular  ny high court judges death ruled a suicide  linklaters atty denies link to husbands alleged fraud  how to manage health care costs and keep lawyers happy  apple vs qualcomm battle heats up what you need to know  dentons scores atty patent team from mofo × already have access click here to login get instant access to the onestop news source for business lawyers register now get instant access to the onestop news source for business lawyers email professional email required first name last name please note a verification email will be sent to your address before you can access your trial password at least  characters required confirm password select at least one primary interest intellectual property life sciences new york show all interests aerospace  defense appellate asset management automotive banking bankruptcy california capital markets class action commercial contracts competition consumer protection corporate cybersecurity  privacy delaware employment energy environmental financial services uk florida food  beverage government contracts health hospitality illinois immigration insurance insurance uk international arbitration international trade law in depth legal ethics media  entertainment medical malpractice mergers  acquisitions native american new jersey pennsylvania private equity product liability project finance public policy real estate retail  e commerce securities sports tax technology telecommunications texas transportation trials white collar register already have access email password forgot your password remember login sign in × sign up for our free intellectual property newsletter you must correct or enter the following before you can sign up please provide a professional email select more newsletters to receive for free aerospace  defense appellate asset management automotive banking bankruptcy california capital markets class action commercial contracts competition consumer protection corporate cybersecurity  privacy delaware employment energy environmental florida food  beverage government contracts health hospitality illinois immigration insurance intellectual property international arbitration international trade law indepth legal ethics legal industry life sciences media  entertainment medical malpractice mergers  acquisitions native american new jersey new york pennsylvania private equity product liability project finance public policy real estate retail  ecommerce securities sports tax technology telecommunications texas transportation trials white collar no thanks sign up now thank you man se otcmktsmagoy stock price news  analysis  marketbeat man se company profile otcmktsmagoy company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about man se otcmktsmagoy industry sector and symbol sector na industry na subindustry na symbol otcmktsmagoy cusip na web na capitalizationmarket cap  billionoutstanding shares average prices week range    petrailing pe ratio pe growth sales  book valueannual revenue  billionprice  sales book value  per shareprice  book dividenddividend yield  profitabilityebidta  millionmiscaverage volume  shs   frequently asked questions for man se otcmktsmagoy what is man ses stock symbol man se trades on the otcmkts under the ticker symbol magoy how often does man se pay dividends what is the dividend yield for man se man se declared a none dividend on thursday june th investors of record on friday may th will be given a dividend of  per share on monday june th the exdividend date of this dividend is wednesday may th view man ses dividend history who are some of man ses key competitors some companies that are related to man se include koninklijke kpn nv kkpny national bank of canada ntiof hannover ruck se hvrry swire pacific swray upmkymmene corp upmky bankia sa eur post cons bnkxf iliad unspon iliay fresnillo plc fnlpf toray inds inc adrrep  tryiy novozymes as nvzmy genmab as dkk gnmsf norsk hydro asa nhydy galp energia sgps sa glpey energias de portugal edpfy lonza group ag lzagy olympus corp ocpny julius baer gruppe jbaxy and ana holdings alnpy how do i buy man se stock shares of man se can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is man ses stock price today one share of man se stock can currently be purchased for approximately  marketbeat community rating for man se otcmkts magoycommunity ranking   out of   outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about man se and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for man se otcmktsmagoy how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown no ratings tracked in the last  monthsconsensus ratingna score nanconsensus price target na analysts ratings history for man se otcmktsmagoy show only the most recent rating from each brokerage all ratings for this stock no equities research coverage for this company has been tracked by marketbeatcom earnings earnings history for man se otcmktsmagoyno earnings announcements for this company have been tracked by marketbeatcom estimates earnings estimates for man se otcmktsmagoyno earnings estimates for this company have been tracked by marketbeatcom dividends dividend history by quarter for man se otcmkts magoyannouncedperiodamountyieldexdividend daterecord datepayable datenonedata available from  forward insider trades insider trading history for man se otcmktsmagoyno insider trades for this company have been tracked by marketbeatcom headlines headline trends for man se otcmktsmagoy latest headlines for man se otcmktsmagoy source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance no headlines for this company have been tracked by marketbeatcom social chart man se magoy chart for friday july   this page was last updated on  by marketbeatcom staff blaine templeman  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in blaine templeman executive vice president secretary and general counsel at aduro biotech view full profile are you blaine templeman claim your profile   sign up for equilar atlas and view blaine templemans full profile with equilar atlas you can identify corporate executives in blaine templemans network and community follow changes in blaine templemans employment and moneyinmotion connect with blaine templeman through your network of contacts blaine templemans executive work history current executive vice president secretary and general counsel aduro biotech past to view blaine templemans complete executive work history sign up now age      blaine templemans biography blaine templeman has served as executive vice president general counsel and secretary since september  prior to joining us mr templeman was a corporate and intellectual property partner at arnold  porter llp a multinational law firm where he counseled us and international clients on the protection development and commercialization of their products intellectual property portfolios contract manufacturing clinical trials research and outsourcing prior to joining arnold  porter llp in  mr templeman served as a partner at sheppard mullin richter  hampton llp a multinational law firm since  mr templeman holds a  read more blaine templeman has served as executive vice president general counsel and secretary since september  prior to joining us mr templeman was a corporate and intellectual property partner at arnold  porter llp a multinational law firm where he counseled us and international clients on the protection development and commercialization of their products intellectual property portfolios contract manufacturing clinical trials research and outsourcing prior to joining arnold  porter llp in  mr templeman served as a partner at sheppard mullin richter  hampton llp a multinational law firm since  mr templeman holds a jd from new york university and a bs from oral roberts university source aduro biotech on    sign up for equilar atlas and view blaine templemans full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like blaine templeman more specifically youll be able to identify corporate executives in blaine templemans network and community follow changes in blaine templemans employment and moneyinmotion connect with blaine templeman through your network of conections view full profile   search for over  executive profiles bio example blaine templeman blaine templemans connections  sign up now to view blaine templemans  connections » frank mccormick former board member aduro biotech gerald chan former board member aduro biotech stephanie m obrien former board member aduro biotech william m greenman dir president and chief executive officer cerus corporation stephen t isaacs chairman of the board president and chief executive officer aduro biotech ross haghighat board member aduro biotech gregory w schafer chief operating officer aduro biotech stephen a sherwin board member neurocrine biosciences inc natalie sacks chief medical officer aduro biotech thomas w dubensky chief scientific officer aduro biotech popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   aduro biotech appoints blaine templeman as executive vice president general counsel and secretary nasdaqadro english français register sign in aduro biotech appoints blaine templeman as executive vice president general counsel and secretary september    et  source aduro biotech inc berkeley calif sept   globe newswire  aduro biotech inc nasdaqadro today announced that blaine templeman has joined the company as executive vice president general counsel and secretary of aduro mr templeman has over  years of experience counseling biotechnology companies in the development and commercialization of their products and the protection of their intellectual property portfolios blaine has served as aduros legal counsel for several years and has played a critical role in our major business milestones which include finalizing our partnerships with novartis and janssen said stephen t isaacs chairman president and chief executive officer of aduro we are thrilled to have him as a member of our leadership team where his experience will be invaluable as we continue to opportunistically evaluate and pursue the development of our key programs both organically and through partnerships with other industry leaders prior to joining aduro mr templeman was a corporate and intellectual property partner at arnold  porter llp where he counseled us and international clients on the protection development and commercialization of their products intellectual property portfolios contract manufacturing clinical trials research and outsourcing  his transactional experience includes a variety of collaborations licensing transactions mergers and acquisitions asset sales manufacturing and distribution arrangements and copromotion transactions before arnold  porter llp he was a partner at heller ehrman mr templeman holds a jd from new york university and a bs from oral roberts university about aduro aduro biotech inc nasdaqadro is a clinicalstage immunotherapy company focused on the discovery development and commercialization of therapies that transform the treatment of challenging diseases aduros technology platforms which are designed to harness the bodys natural immune system are being investigated in cancer indications and have the potential to expand into autoimmune and infectious diseases aduros ladd technology platform is based on proprietary attenuated strains of listeria that have been engineered to express tumorassociated antigens to induce specific and targeted immune responses based on compelling clinical data in advanced cancers this platform is being developed as a treatment for multiple indications including pancreatic lung and prostate cancers mesothelioma and glioblastoma aduros cyclic dinucleotide cdn platform is designed to activate the intracellular sting receptor resulting in a potent tumorspecific immune response aduro is collaborating with leading global pharmaceutical companies to expand its products and technology platforms for more information please visit wwwadurocom cautionary note on forwardlooking statements this press release contains forwardlooking statements for purposes of the safe harbor provisions of the private securities litigation reform act of  forwardlooking statements include statements regarding our intentions or current expectations concerning among other things our technology platforms and development programs in some cases you can identify these statements by forwardlooking words such as believe may will estimate potential anticipate intend could would project plan expect or the negative or plural of these words or similar expressions forwardlooking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated including but not limited to our history of net operating losses and uncertainty regarding our ability to achieve profitability our ability to develop and commercialize our product candidates our ability to use and expand our technology platforms to build a pipeline of product candidates our dependence on our lead product candidate crs and gvax pancreas our ability to obtain and maintain regulatory approval of our product candidates our inability to operate in a competitive industry and compete successfully against competitors that have greater resources than we do our reliance on third parties and our ability to obtain and adequately protect intellectual property rights for our product candidates we discuss many of these risks in greater detail under the heading risk factors contained in the most recent form q which is on file with the securities and exchange commission forwardlooking statements are not guarantees of future performance and our actual results of operations financial condition and liquidity and the development of the industry in which we operate may differ materially from the forwardlooking statements contained in this press release any forwardlooking statements that we make in this press release speak only as of the date of this press release we assume no obligation to update our forwardlooking statements whether as a result of new information future events or otherwise after the date of this press release sylvia wheeler svp corporate affairs    media contact angela bitting    pressadurocom related articles other press releases by aduro biotech inc aduro biotech announces andrea van elsas phd to be named chief scientific officer effective september   july    aduro announces milestone achieved relating to collaboration with merck for development of anticd antibody for the treatment of cancer july    aduro biotech announces initiation of phase  clinical trial of crs in combination with keytruda® pembrolizumab for the treatment of previouslytreated gastroesophageal adenocarcinoma june    aduro biotech announces first patient dosed in phase  clinical trial of crs in combination with keytruda® pembrolizumab for the treatment of patients with previously treated malignant pleural mesothelioma june    aduro biotech announces fda clearance of investigational new drug application to evaluate the combination of adus with pdr for the treatment of solid tumors and lymphomas june     other news releases in directors and officers in the last  days profile aduro biotech inc   subscribe via rss  subscribe via atom  javascript berkeley california united states contact data sylvia wheeler svp corporate affairs    media contact angela bitting    pressadurocom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files aduro biotech inc logo logo url  copy the link below formats available original medium small tags biotechnology management changes newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved mr blaine templeman  american conference institute toggle navigation home mr blaine templeman partner at sheppard mullin richter  hamilton llp blaine templeman is a partner in the intellectual property practice group in the firms new york office mr templemans practice focuses on us and crossborder intellectual property transactions drug manufacturing and clinical trials outsourcing and contracting his transactional work focuses on asset deals collaborations licensing transactions distribution arrangements and copromotions he has assisted clients in a variety of industries including among many others medical devices vaccines antibiotics diabetes oncology and sexual dysfunction at a prior firm mr templeman completed one of the largest ever us biotechbiotech mergers mr templeman is also the head of the firms new clinical contracting team which services our clients needs with respect to clinical trials agreements cro agreements master service agreements laboratory agreements manufacturing agreements including development api and finished product agreements research arrangements and other similar agreements he has completed clinical trials arrangements with hundreds of clinical sites around the world he has also worked closely with several of his clients to complete transactions in the us eu russia australia new zealand india japan korea taiwan brazil argentina peru mexico and many other countries mr templeman is one of only  attorneys in the ny area that have been named a best lawyer in america for biotechnology law tweets by acilegal latest blog posts hear from top fda regulatory experts at aci’s th annual fda boot camp devices edition pharmaceuticals  biotech  life sciences by american conference institute  jun   aci’s fda boot camp to feature a “who’s who” of the fda regulatory bar pharmaceuticals  biotech  life sciences by american conference institute  jun   highlights of keynote address at aci’s brazil summit on anticorruption anticorruption  fcpa by american conference institute  may   law highlights aci pto proceedings ptab judges roundtable intellectual property by american conference institute  may   aci’s pto proceedings covered by law intellectual property by american conference institute  may   view conferences by location by sector featured view cart continue shopping close templeman blaine  aduro biotech insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailstempleman blaineaduro biotech adroexecutive vp general counsel not rankedtempleman blaines performancetempleman blaine has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked insider holdings  aduro biotech adroksee the top stocks by insiders  insider rolesaduro biotech adro executive vp general counselsee the top  corporate insiders  templeman blaines trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction dateadroaduro biotechexecutive vp general counseluninformative sellmay  templeman blaine has not reported any informative transactions for adro therefore performance cannot be measured track record datetransactionamountno of sharesprice per shareprofitform  may   uninformative sell k   na jan   uninformative sell k   na sep   uninformative buy    na show moresee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by blaine templeman executive vice president general counsel and secretary aduro biotech timesjavascript is disabled market profiles login sign up login sign up   edit person blaine templeman executive vice president general counsel and secretary at aduro biotech location new york ny add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop blaine templeman executive vice president general counsel and secretary at aduro biotech location new york ny add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop blaine templeman joined aduro as executive vice president general counsel and secretary in september  he brings over  years of experience counseling biotechnology companies in the development and commercialization of their products prior to joining aduro mr templeman was a corporate and intellectual property partner at arnold  porter llp where he counseled us and international clients on the protection development and commercialization of their products intellectual property portfolios contract manufacturing clinical trials research and outsourcing his transactional experience includes a variety of collaborations licensing transactions mergers and acquisitions asset sales manufacturing and distribution arrangements and copromotion transactions before arnold  porter llp he was a partner at heller ehrman mr templeman holds a jd from new york university and a bs from oral roberts university  companies in career na related markets  colleagues na related investments alias na industry offices of lawyers tags intellectual property corporate law medical devices topics of influence web site na careers achievements investments related people edit view all blaine templemancareer  sep aduro biotech executive vice president general counsel and secretary oct to sep arnold  porter partner  to oct sheppard mullin richter  hampton partner competencies edit view all blaine templemaneducation   new york university school of law  princeton theological seminary m divinity program candidate  oral roberts university edit blaine templemanachievements and recognitions add milestone no milestones has been recorded for blaine templeman edit blaine templemanlinks add link no links has been recorded for blaine templeman blaine templemaninvestmentsacquisitions no investments has been recorded for blaine templeman blaine templemaninvestments representing others no investment reps has been recorded for blaine templeman blaine templemanrelated people colleagues at aduro biotech liana wu vp commercial apr sylvia wheeler senior vice president corporate affairs and investor relations feb jennifer lew senior vice president finance oct gregory w schafer chief operating officer jul view all peers  michael duffy vice president general counsel and secretary of lantheus holdings robert evans executive vice president and general counsel of penumbra andy missan executive vice president  general counsel of fitbit gwendolyn binderscholl executive vice president of adaptimmune frances toneguzzo executive vice president of nantkwest anders blom executive vice president of oasmia pharmaceutical view all blaine templemanrecommended market profiles healthcare ipo companies  or more employees  companies blaine templeman  arnold  porter  executive moves  crains new york business login register contact us subscribe advertising section executive moves keywords law male new hire arnold  porter blaine templeman new hire published on october   blaine templeman  joined arnold  porter as partner he was formerly partner at sheppard mullin job title partner company arnold  porter age   start date october   newly created position no job function legal  attorney job description blaine templeman is a partner in arnold  porters new york office and a member of the corporate and securities and intellectual property groups as well as a member of the firms life sciences team his practice focuses on counseling us and international clients in the protection development and commercialization of their products and ip portfolios through domestic and crossborder intellectual property transactions precision manufacturing contract manufacturing clinical trials research and outsourcing his transactional work includes mergers and acquisitions asset sales collaborations licensing transactions manufacturing and distribution arrangements and copromotion transactions former job title partner former company sheppard mullin industry law company headquarters washington dc company description arnold  porter is an international law firm of nearly  lawyers with offices in brussels denver houston london los angeles new york san francisco silicon valley and washington dc the firm founded in  maintains more than  practice areas spanning a broad spectrum of the law with a primary focus on litigation transactional matters and regulatory issues  office location  park ave new york ny submit an executive move advanced search frequently asked questions executive moves alerts sign up to receive our monthly email with the latest executive promotions new hires and board appointments view sample     newsletters